5-MeO-2-TMT
![]()  | |
| Systematic (IUPAC) name | |
|---|---|
| 
 2-(5-methoxy-2-methyl-H-indol-3-yl)-N,N-dimethylethanamine  | |
| Identifiers | |
| CAS Number | 67292-68-6 | 
| PubChem | CID 49756 | 
| ChemSpider | 
45143  | 
| ChEMBL | 
CHEMBL7143  | 
| Chemical data | |
| Formula | C14H20N2O | 
| Molar mass | 232.321 g/mol | 
  | |
  | |
| (verify) | |
5-Methoxy-2,N,N-trimethyltryptamine (5-MeO-2,N,N-TMT, 5-MeO-TMT) is a psychoactive drug of the tryptamine chemical class which acts as a psychedelic. It was first synthesized by Alexander Shulgin and reported in his book TiHKAL ("Tryptamines i Have Known And Loved").[1] 5-MeO-TMT is claimed to show psychoactive effects at a dosage of 75-150 mg orally, but these are relatively mild compared to those of other similar compounds. This suggests that while the methyl group on the 2-position of the molecule has impaired the binding of metabolic enzymes like monoamine oxidase (MAO), it is also interfering with binding to and/or activation of the serotonin 5-HT2A receptor, the target responsible for mediating the hallucinogenic effects of such compounds.
See also
- 2,N,N-Trimethyltryptamine (2,N,N-TMT)
 - 5-MeO-7-TMT
 
References
External links
  | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
  | ||||||
